Virtual Reality Application in Chemotherapy

May 27, 2021 updated by: Taipei Medical University
The present study wants to design a training program for chemotherapy with using VR. Then the investigators design a protocol to compare the training effects in the VR program and ISO document.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

As technology advances, mobile devices have gradually turned into wearable devices. Furthermore, virtual reality (VR), augmented reality (AR), and mixed reality (MR) are being increasingly applied in medical fields such as medical education and training, surgical simulation, neurological rehabilitation, psychotherapy, and telemedicine. Research results demonstrate the ability of VR, AR, and MR to ameliorate the inconveniences that are often associated with traditional medical care, reduce incidents of medical malpractice caused by unskilled operations, and reduce the cost of medical education and training. What is more, the application of these technologies has enhanced the effectiveness of medical education and training, raised the level of diagnosis and treatment, improved the doctor-patient relationship, and boosted the efficiency of medical execution. The present study wants to design a training program for chemotherapy with using VR. Then the investigators design a protocol to compare the training effects in VR program and ISO document.

Study Type

Interventional

Enrollment (Actual)

77

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
      • Taipei county, Taiwan
        • Taipei Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. The staffs who require to implement chemotherapy skill in the hospital.
  2. Age over 20 years.

Exclusion Criteria:

1. Refuse to join the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Intervention
The experimental group uses the VR program to training chemotherapy skill. Use VR software to make a training education program.
Behavioral: VR training program
Use VR software to make a training education program.
NO_INTERVENTION: usual care
Chemotherapy training as usual care (for training chemotherapy skill).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The questionnaire about intervention effect
Time Frame: After intervention 1 week, to perform the test. Including the content design, the convenience, the effectiveness, and promotion.
After intervention, the investigator want to know the effect of intervention. A total of 12 questions, using the Likert's scale, very disagree(1) to very agree(5). It will compute a total score, score high means more effective.
After intervention 1 week, to perform the test. Including the content design, the convenience, the effectiveness, and promotion.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The questionnaire of Knowledge level for chemotherapy technique
Time Frame: Before the intervention, the investigator perform a pretest. After intervention 1 week, the investigator perform the post test.
The questionnaire want to understand the Knowledge for chemotherapy operation skill before and after intervention. A total of ten questions, with scores ranging from 0 to 10 points. , score high means more correct.
Before the intervention, the investigator perform a pretest. After intervention 1 week, the investigator perform the post test.
The questionnaire of Attitude for chemotherapy operation
Time Frame: Before the intervention, the investigator perform a pretest. After intervention 1 week, the investigator perform the post test.
The questionnaire want to understand the Attitude for chemotherapy operation skill before and after intervention. A total of ten questions, using the likert's scale, very disagree with 1 point, very agree with 5 points, total scores between 10 points and 50 points. , score high means more active.
Before the intervention, the investigator perform a pretest. After intervention 1 week, the investigator perform the post test.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Taipei Medical University

Collaborators

Taipei Medical University WanFang Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 11, 2018

Primary Completion (ACTUAL)

November 30, 2019

Study Completion (ACTUAL)

November 30, 2019

Study Registration Dates

First Submitted

October 2, 2018

First Submitted That Met QC Criteria

October 15, 2018

First Posted (ACTUAL)

October 16, 2018

Study Record Updates

Last Update Posted (ACTUAL)

May 28, 2021

Last Update Submitted That Met QC Criteria

May 27, 2021

Last Verified

July 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • N201902009 (REGISTRY: TMU-JIRB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chemotherapy Training

Clinical Trials on VR training program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe